Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:15 pm Unchanged | 2026-05-15 | 13G | BIOAGE LABS INC BIOA | Khosla Ventures VI, LP | 1,798,702 4.000% | 0 (Unchanged) | Filing History |
| 2026-05-15 1:18 pm Purchase | 2026-03-31 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,890,605 6.510% | 850,000 (+41.65%) | Filing History |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | BIOAGE LABS INC BIOA | BlackRock, Inc. BLK | 2,236,460 5.030% | 2,236,460 (New Position) | Filing History |
| 2026-02-17 6:23 pm Sale | 2025-12-31 | 13G | BIOAGE LABS INC BIOA | ADAR1 Capital Management, LLC | 135,560 0.400% | -1,801,563 (-93.00%) | Filing History |
| 2026-02-17 3:02 pm Sale | 2025-12-31 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,040,605 5.690% | -100,000 (-4.67%) | Filing History |
| 2026-02-13 4:18 pm Purchase | 2025-12-31 | 13G | BIOAGE LABS INC BIOA | Fortney Kristen | 2,704,736 7.200% | 373,664 (+16.03%) | Filing History |
| 2025-08-14 8:07 pm Purchase | 2025-06-30 | 13G | BIOAGE LABS INC BIOA | ADAR1 Capital Management, LLC | 1,937,123 5.400% | 1,937,123 (New Position) | Filing History |
| 2025-08-14 3:01 pm Sale | 2025-06-30 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,140,605 5.970% | -488,924 (-18.59%) | Filing History |
| 2025-02-14 6:27 pm Sale | 2024-12-31 | 13G | BIOAGE LABS INC BIOA | RA CAPITAL MANAGEMENT L.P. | 1,310,589 3.700% | -900,000 (-40.71%) | Filing History |
| 2025-02-14 3:00 pm Purchase | 2024-12-31 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,629,529 7.340% | 2,629,529 (New Position) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | BIOAGE LABS INC BIOA | Khosla Ventures VI, LP | 1,798,702 5.000% | 1,798,702 (New Position) | Filing History |
| 2024-11-12 4:15 pm Purchase | 2024-09-30 | 13G | BIOAGE LABS INC BIOA | Fortney Kristen | 2,331,072 6.600% | 2,331,072 (New Position) | Filing History |
| 2024-10-07 4:16 pm Purchase | 2024-09-27 | 13G | BIOAGE LABS INC BIOA | RA CAPITAL MANAGEMENT L.P. | 2,210,589 6.200% | 2,210,589 (New Position) | Filing History |
| 2024-10-04 8:21 pm Purchase | 2024-09-27 | 13D | BIOAGE LABS INC BIOA | AH Bio Fund I, L.P. | 3,233,170 9.000% | 3,233,170 (New Position) | Filing History |
| 2024-09-30 8:34 pm Purchase | 2024-09-27 | 13D | BIOAMBER INC, BIOAQ | Sofinnova Venture Partners XI, L.P. ("SVP XI") | 2,304,901 6.700% | 2,304,901 (New Position) | Filing History |